About
Technology
Issues
FAQ
Links
Official Page
Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.